• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞穿透肽的癌症靶向应用

Cancer-Targeting Applications of Cell-Penetrating Peptides.

作者信息

Moreno-Vargas Liliana Marisol, Prada-Gracia Diego

机构信息

Research Unit on Computational Biology and Drug Design, Children's Hospital of Mexico Federico Gómez, Mexico City 06720, Mexico.

出版信息

Int J Mol Sci. 2024 Dec 24;26(1):2. doi: 10.3390/ijms26010002.

DOI:10.3390/ijms26010002
PMID:39795861
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11720565/
Abstract

Cell-penetrating peptides (CPPs) offer a unique and efficient mechanism for delivering therapeutic agents directly into cancer cells. These peptides can traverse cellular membranes, overcoming one of the critical barriers in drug delivery systems. In this review, we explore recent advancements in the application of CPPs for cancer treatment, focusing on mechanisms, delivery strategies, and clinical potential. The review highlights the use of CPP-drug conjugates, CPP-based vaccines, and their role in targeting and inhibiting tumor growth.

摘要

细胞穿透肽(CPPs)为将治疗剂直接递送至癌细胞提供了一种独特且高效的机制。这些肽能够穿过细胞膜,克服了药物递送系统中的关键障碍之一。在本综述中,我们探讨了CPPs在癌症治疗应用中的最新进展,重点关注其作用机制、递送策略及临床潜力。该综述强调了CPP-药物偶联物、基于CPPs的疫苗的应用及其在靶向和抑制肿瘤生长中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d6/11720565/40059575f186/ijms-26-00002-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d6/11720565/481ca2896a70/ijms-26-00002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d6/11720565/5bfb224ae366/ijms-26-00002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d6/11720565/40059575f186/ijms-26-00002-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d6/11720565/481ca2896a70/ijms-26-00002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d6/11720565/5bfb224ae366/ijms-26-00002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d6/11720565/40059575f186/ijms-26-00002-g003.jpg

相似文献

1
Cancer-Targeting Applications of Cell-Penetrating Peptides.细胞穿透肽的癌症靶向应用
Int J Mol Sci. 2024 Dec 24;26(1):2. doi: 10.3390/ijms26010002.
2
The Current Role of Cell-Penetrating Peptides in Cancer Therapy.细胞穿透肽在癌症治疗中的当前作用
Adv Exp Med Biol. 2017;1030:279-295. doi: 10.1007/978-3-319-66095-0_13.
3
Cell-penetrating peptides: strategies for anticancer treatment.细胞穿透肽:抗癌治疗策略。
Trends Mol Med. 2015 Sep;21(9):560-70. doi: 10.1016/j.molmed.2015.06.005. Epub 2015 Jul 15.
4
Applications of cell penetrating peptide-based drug delivery system in immunotherapy.基于细胞穿透肽的药物递送系统在免疫治疗中的应用。
Front Immunol. 2025 Jan 22;16:1540192. doi: 10.3389/fimmu.2025.1540192. eCollection 2025.
5
Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.利用细胞穿透肽和肿瘤靶向肽进行抗癌药物传递的最新进展。
J Control Release. 2017 Mar 28;250:62-76. doi: 10.1016/j.jconrel.2017.02.006. Epub 2017 Feb 4.
6
Peptide-Based Therapeutics in Cancer Therapy.基于肽的癌症治疗疗法。
Mol Biotechnol. 2024 Oct;66(10):2679-2696. doi: 10.1007/s12033-023-00873-1. Epub 2023 Sep 28.
7
Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging.用于癌症靶向治疗与成像的细胞穿透肽
Curr Cancer Drug Targets. 2015;15(4):337-51. doi: 10.2174/1568009615666150211104524.
8
Advances and prospects of cell-penetrating peptides in tumor immunotherapy.细胞穿透肽在肿瘤免疫治疗中的研究进展与展望
Sci Rep. 2025 Jan 27;15(1):3392. doi: 10.1038/s41598-025-86130-8.
9
Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.基于细胞穿透/肿瘤靶向肽修饰的纳米载体实现草药药物的肿瘤靶向递释。
Int J Nanomedicine. 2018 Mar 9;13:1425-1442. doi: 10.2147/IJN.S156616. eCollection 2018.
10
Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents.酶触发的、细胞穿透肽介导的抗肿瘤药物传递。
J Control Release. 2016 Oct 28;240:67-76. doi: 10.1016/j.jconrel.2015.10.040. Epub 2015 Oct 26.

引用本文的文献

1
Development of a KRP-based pH-responsive drug delivery system for solid tumors.基于KRP的实体瘤pH响应型药物递送系统的研发
Transl Cancer Res. 2025 Jun 30;14(6):3812-3821. doi: 10.21037/tcr-2025-1151. Epub 2025 Jun 27.
2
Peptide-Based Nanoparticle for Tumor Therapy.用于肿瘤治疗的肽基纳米颗粒
Biomedicines. 2025 Jun 9;13(6):1415. doi: 10.3390/biomedicines13061415.
3
GRA16 Suppresses Aerobic Glycolysis by Downregulating c-Myc and TERT Expressions in Colorectal Cancer Cells.GRA16通过下调结肠癌细胞中的c-Myc和TERT表达来抑制有氧糖酵解。

本文引用的文献

1
A translational study for biomarker identification of PEP-010, a pro-apoptotic peptide restoring apoptosis in cancer models.一项关于PEP-010生物标志物鉴定的转化研究,PEP-010是一种能在癌症模型中恢复细胞凋亡的促凋亡肽。
Biochim Biophys Acta Mol Basis Dis. 2025 Jan;1871(1):167492. doi: 10.1016/j.bbadis.2024.167492. Epub 2024 Aug 30.
2
The first-in-class pro-apoptotic peptide PEP-010 is effective in monotherapy and in combination with paclitaxel on resistant ovarian adenocarcinoma cell models.一流的促凋亡肽PEP - 010在单药治疗以及与紫杉醇联合治疗耐药性卵巢腺癌细胞模型方面有效。
Front Pharmacol. 2024 Aug 7;15:1444973. doi: 10.3389/fphar.2024.1444973. eCollection 2024.
3
Biomol Ther (Seoul). 2025 Jul 1;33(4):621-635. doi: 10.4062/biomolther.2025.040. Epub 2025 Jun 25.
Structural regression modelling of peptide based drug delivery vectors for targeted anti-cancer therapy.
用于靶向抗癌治疗的基于肽的药物递送载体的结构回归建模
Drug Deliv Transl Res. 2025 Apr;15(4):1284-1298. doi: 10.1007/s13346-024-01674-y. Epub 2024 Aug 8.
4
MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumors.苏来麦迪林对MDM2/MDMX的抑制作用与抗程序性死亡1免疫疗法在野生型p53肿瘤中具有协同作用。
iScience. 2024 May 6;27(6):109862. doi: 10.1016/j.isci.2024.109862. eCollection 2024 Jun 21.
5
Short Fragmented Peptides from Exhibit Stronger Anticancer Activities in Residue Replacement and Analyses.短片段肽在残基替换和分析中表现出更强的抗癌活性。
Curr Drug Discov Technol. 2024;21(6):e220224227304. doi: 10.2174/0115701638290855240207114727.
6
Anticancer activities of natural antimicrobial peptides from animals.动物源天然抗菌肽的抗癌活性
Front Microbiol. 2024 Jan 17;14:1321386. doi: 10.3389/fmicb.2023.1321386. eCollection 2023.
7
MT1-MMP as a Key Regulator of Metastasis.MT1-MMP 作为转移的关键调节因子。
Cells. 2023 Aug 31;12(17):2187. doi: 10.3390/cells12172187.
8
Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development.苏兰那敏(ALRN-6924)的发现,首个临床开发的细胞穿透性、稳定的α-螺旋肽。
J Med Chem. 2023 Jul 27;66(14):9401-9417. doi: 10.1021/acs.jmedchem.3c00623. Epub 2023 Jul 13.
9
Anticancer activity of derived peptide with iRGD in colon cancer therapy.含iRGD的衍生肽在结肠癌治疗中的抗癌活性。
Iran J Basic Med Sci. 2023;26(7):768-776. doi: 10.22038/IJBMS.2023.68331.14913.
10
Cell Penetrating Peptides: Classification, Mechanisms, Methods of Study, and Applications.细胞穿透肽:分类、作用机制、研究方法及应用
ChemMedChem. 2023 Sep 1;18(17):e202300236. doi: 10.1002/cmdc.202300236. Epub 2023 Jul 26.